Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | TSHR | P16473 | 4/20 | 0.40 |
| ▸ | FDPS | P14324 | 3/20 | 0.36 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.35 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.35 |
| ▸ | DNM1 | Q05193 | 2/20 | 0.34 |
| ▸ | ADH1B | P00325 | 1/20 | 0.34 |
| ▸ | ADH1C | P00326 | 1/20 | 0.34 |
| ▸ | ADH1A | P07327 | 1/20 | 0.34 |
| ▸ | ADH4 | P08319 | 1/20 | 0.34 |
| ▸ | ADH7 | P40394 | 1/20 | 0.34 |
| ▸ | SMPD1 | P17405 | 2/20 | 0.33 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15922971 | 1.00 | LMNA (0.45) | LMNATSHRFDPSPRSS1PRSS2 | |
| SCHEMBL15922096 | 1.00 | LMNA (0.45) | LMNATSHRFDPSPRSS1PRSS2 | |
| SCHEMBL2870768 | 1.00 | LMNA (0.45) | LMNATSHRFDPSPRSS1PRSS2 | |
| SCHEMBL15922428 | 1.00 | LMNA (0.45) | LMNATSHRFDPSPRSS1PRSS2 | |
| SCHEMBL15922987 | 1.00 | LMNA (0.45) | LMNATSHRFDPSPRSS1PRSS2 | |
| SCHEMBL18675773 | 1.00 | LMNA (0.45) | LMNATSHRFDPSPRSS1PRSS2 | |
| SCHEMBL2870770 | 1.00 | LMNA (0.45) | LMNATSHRFDPSPRSS1PRSS2 | |
| SCHEMBL15923040 | 1.00 | LMNA (0.45) | LMNATSHRFDPSPRSS1PRSS2 | |
| SCHEMBL17311977 | 1.00 | LMNA (0.45) | LMNATSHRFDPSPRSS1PRSS2 | |
| SCHEMBL15923191 | 1.00 | LMNA (0.45) | LMNATSHRFDPSPRSS1PRSS2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 38 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180210362-A1 | METHOD OF PRODUCING CURABLE LIQUID DEVELOPER AND CURABLE LIQUID DEVELOPER | CANON KK (JP) | 2018-07-26 | — | — | US | disclosed |
| US-20180143546-A1 | METHOD FOR PRODUCING CURABLE LIQUID DEVELOPER | CANON KABUSHIKI KAISHA (JP) | 2018-05-24 | — | — | US | disclosed |
| US-9971268-B2 | Curable liquid developer having a cationically polymerizable liquid monomer with a monofunctional vinyl ether compound | CANON KABUSHIKI KAISHA (JP) | 2018-05-15 | — | — | US | disclosed |
| US-9926474-B2 | Pressure-sensitive adhesive compositions and adhesive articles including the same | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2018-03-27 | — | — | US | disclosed |
| US-20180059566-A1 | UV-CURABLE LIQUID DEVELOPER, FIXING METHOD, IMAGE FORMING METHOD, AND UV-CURABLE COMPOSITION | CANON KABUSHIKI KAISHA (JP) | 2018-03-01 | — | — | US | disclosed |
| US-9897936-B2 | Method of producing curable liquid developer and curable liquid developer | CANON KABUSHIKI KAISHA (JP) | 2018-02-20 | — | — | US | disclosed |
| US-20180046105-A1 | CURABLE LIQUID DEVELOPER | CANON KABUSHIKI KAISHA (JP) | 2018-02-15 | — | — | US | disclosed |
| US-20180046106-A1 | LIQUID DEVELOPER AND METHOD OF PRODUCING SAID LIQUID DEVELOPER | CANON KABUSHIKI KAISHA (JP) | 2018-02-15 | — | — | US | disclosed |
| US-9891546-B2 | Ultraviolet-curable liquid developer | CANON KABUSHIKI KAISHA (JP) | 2018-02-13 | — | — | US | disclosed |
| US-9891547-B2 | Ultraviolet-curable liquid developer | CANON KABUSHIKI KAISHA (JP) | 2018-02-13 | — | — | US | disclosed |
| US-20160349652-A1 | METHOD OF PRODUCING CURABLE LIQUID DEVELOPER AND CURABLE LIQUID DEVELOPER | CANON KABUSHIKI KAISHA (JP) | 2016-12-01 | — | — | US | disclosed |
| EP-3098659-A1 | CURABLE LIQUID DEVELOPER AND IMAGE-FORMING METHOD USING CURABLE LIQUID DEVELOPER | Canon Kabushiki Kaisha (JP) | 2016-11-30 | — | — | EP | disclosed |
| WO-2016171284-A1 | CURABLE LIQUID DEVELOPER | CANON KABUSHIKI KAISHA (JP) | 2016-10-27 | — | — | WO | disclosed |
| WO-2016111380-A1 | ULTRAVIOLET CURABLE LIQUID COMPOSITION, ULTRAVIOLET CURING INKJET INK, ULTRAVIOLET CURING WET ELECTROPHOTOGRAPHIC LIQUID DEVELOPER, ULTRAVIOLET CURING ELECTROSTATIC INKJET INK, AND IMAGE FORMING METHOD USING THEREOF | CANON KABUSHIKI KAISHA (JP) | 2016-07-14 | — | — | WO | disclosed |
| US-20150353785-A1 | PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS AND ADHESIVE ARTICLES INCLUDING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY | 2015-12-10 | — | — | US | disclosed |
| EP-2951257-A1 | PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS AND ADHESIVE ARTICLES INCLUDING THE SAME | 3M Innovative Properties Company (US) | 2015-12-09 | — | — | EP | disclosed |
| CN-104981528-A | Pressure-sensitive adhesive compositions and adhesive articles including the same | 3M INNOVATIVE PROPERTIES CO | 2015-10-14 | — | — | CN | disclosed |
| US-20150192875-A1 | ULTRAVIOLET-CURABLE LIQUID DEVELOPER | CANON KABUSHIKI KAISHA (JP) | 2015-07-09 | — | — | US | disclosed |
| US-20150192875-A1 | ULTRAVIOLET-CURABLE LIQUID DEVELOPER | CANON KABUSHIKI KAISHA (JP) | 2015-07-09 | — | — | US | disclosed |
| WO-2014120593-A1 | PRESSURE-SENSITIVE ADHESIVE COMPOSITIONS AND ADHESIVE ARTICLES INCLUDING THE SAME | 3M INNOVATIVE PROPERTIES COMPANY (US) | 2014-08-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180046106-A1 | LIQUID DEVELOPER AND METHOD OF PRODUCING SAID LIQUID DEVELOPER | CCNA1, CCNT1, AUP1 | LMNA 417/4885TSHR 1057/4885FDPS 393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.